ACC.25: Focus on ATTR-CM
ACC.25: Focus on ATTR-CM
Rob DillardACC.25: Focus on ATTR-CM | July 10, 2025
Sudden cardiac death increases amid lower daily temperatures.
Read More
Rob DillardACC.25: Focus on ATTR-CM | July 10, 2025
Acoramidis therapy significantly increases serum transthyretin in people with ATTR-CM compared with tafamidis.
Rob DillardACC.25: Focus on ATTR-CM | July 10, 2025
Patients with single ventricle heart disease commonly have mental health diagnoses.
Rob DillardACC.25: Focus on ATTR-CM | July 10, 2025
Acoramidis therapy induces a significant increase in serum transthyretin, which is typically lower in ATTRv-CM.
Latest News
August 13, 2025